Naflocort anhydrous
- Level
- Commodity
- Parent
- 51421900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51421907This classification denotes a therapeutic glucocorticoid with the molecular formula C29H33FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1V2C47TW7H, chemically known as 2'h-naphtho(2',3':16,17)pregna-1,4-diene-3,20-dione, 9-fluoro-1',4'-dihydro-11,21-dihydroxy-, (11.beta.,16.beta.)-, but more generally known as naflocort anhydrous, which bears US NIH Compound Identifier 64767. European Medicines Agency schedules naflocort anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09124MIG. Most nations, for tariff purposes, schedule naflocort anhydrous under HS 29372200. SMILES: C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(CC5CCCCC5C4)C(=O)CO)CCC6=CC(=O)C=C[C@@]63C)F)O.
Same parent
Under 51421900 · 7Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.